Lymphoma After Relapse: Clinical Trials

1 trial for Lymphoma After Relapse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Lymphoma After Relapse: new trials by email Literature Review of Lymphoma After Relapse trials Research Report on Lymphoma After Relapse

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi) - Leukemia, Acute Myeloid Leukemia in Remission
Not applicableRecruitingMedical College of Wisconsin402023-05-012026-05-13

Narrower conditions

Anemia, Refractory, with Excess of Blasts (1)  ·  Burkitt Lymphoma (1)  ·  Leukemia (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Myeloid, Accelerated Phase (1)  ·  Leukemia, Myeloid, Chronic-Phase (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Anemia (1)  ·  Anemia, Refractory (1)  ·  Bone Marrow Diseases (1)  ·  Chronic Disease (1)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Epstein-Barr Virus Infections (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)

Sponsors

Medical College of Wisconsin (1)

Countries

United States (1)